Cumulus Oncology

Edinburgh-based cancer therapeutics development specialist Cumulus Oncology has successfully secured a £9 million funding package, including a significant contribution of £6m from the Scottish National Investment Bank. The funds are earmarked to bolster Cumulus's portfolio of companies d

Edinburgh-based Cumulus Oncology has appointed Nicola Broughton as a non-executive director as Europe’s first oncology drug discovery accelerator continues in scale-up mode and targets its next investment round. Ms Broughton, a former investment director at Mercia Asset Management, is the mana

Edinburgh-headquartered Cumulus Oncology, Europe’s first oncology drug discovery accelerator, is eyeing global alliances, VC partnerships and a US office opening in 2021, with CEO and co-founder Clare Wareing seeing additional growth opportunities in Europe and Asia. The company is also lookin

St Andrews-based investment firm Eos Advisory has backed Europe’s first oncology drug discovery accelerator, Cumulus Oncology, leading a £1.7 million investment round. The funding round was supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise, Alba Equity,